EUVIMEDEUVIMED entdecken
Crossref

CD44 Receptor-Guided Hyaluronic Acid Nanogels with Dual-Stimuli Responsiveness and Lysosomal Disruption Capability for In Vivo Protein Delivery in Lung Cancer Treatment

Wei Jiang, Wei Sun, Siqi Zhan, Changling Liu, Li Sheng, Yan Fu, Jung Hee Lee, Tianjia Liu, Baiji Xue, Moon-Sun Jang, Hong Yu Yang iD

Biomacromolecules · 2026

DOI: 10.1021/acs.biomac.6c01379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomacromolecules, 2026. Verfasst von Wei Jiang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Materials Science and Engineering, Jilin University of Chemical Technology, Jilin, 132022Jilin Province, P. R. China. Hauptthemen laut MEDLINE: Lung Neoplasms, Hyaluronic Acid, Hyaluronan Receptors, Lysosomes. Die Arbeit nennt 55 Literaturangaben. Gefördert von: Science and Technology Innovation Development Program of Jilin City, Scientific Research Project of Education Department of Jilin Province, Natural Science Foundation of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein delivery nanosystems must balance stable loading, barrier navigation, and targeted, controlled release. Herein, a pH/ROS dual-responsive nanogel (PRNG) was constructed by forming dynamic boronic ester crosslinkers between PEGylated hyaluronic acid bearing diethylenetriamine-grafted-catechol groups (PEG-HA-Dien-CA) and hyaluronic acid-conjugated phenylboronic acid (HA-PBA) for cytoplasmic cytochrome c (CC) delivery. This pioneering conceptual design not only facilitates the formation of stable nanocarriers with a high CC loading capacity, but also presents a distinctive mechanism for dual-responsive protein release. Confocal imaging confirmed that CC-loaded PRNG was efficiently internalized by A549 cells through CD44-dependent endocytosis, rapidly released from the endo/lysosomal compartments, and effectively delivered CC into the cytoplasm, and subsequently induced cell apoptosis in the acidic tumor microenvironment (TME) rich in H2O2. In mice bearing human lung tumors, CC-loaded PRNGs preferentially accumulate at tumor sites and effectively inhibit growth with minimal systemic toxicity, demonstrating a versatile nanoplatform for lung cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsHyaluronic AcidHyaluronan ReceptorsLysosomesCytochromes cNanogelsHumansAnimalsMiceBoronic AcidsA549 CellsPolyethylene GlycolsApoptosisHydrogen-Ion ConcentrationDrug Delivery SystemsPolyethyleneimine

Stichwörter der Autor:innen

endo/lysosomal escapenanogelpH/ROS dual-responsiveprotein therapy

Substanzen

Hyaluronic AcidHyaluronan ReceptorsBoronic AcidsCytochromes cNanogelsCD44 protein, humanbenzeneboronic acidpolyethylene glycol polyethyleneimine nanogelPolyethylene GlycolsPolyethyleneimine

Autor:innen und Institutionen

  • College of Materials Science and Engineering, Jilin University of Chemical Technology, Jilin, 132022Jilin Province, P. R. China.
  • Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine and Center for Molecular and Cellular Imaging, Samsung Biomedical Research Institute, Seoul06351, Republic of Korea.
  • Pharmaceutical Research and Development Center, Baicheng Medical College, Baicheng, 137000Jilin Province, P. R. China.

ORCID-Profile: Hong Yu Yang

Förderung

  • Science and Technology Innovation Development Program of Jilin City
  • Scientific Research Project of Education Department of Jilin Province
  • Natural Science Foundation of Jilin Province

Zitieren

APA

Jiang, W., Sun, W., Zhan, S., Liu, C., Sheng, L., Fu, Y., Lee, J. H., Liu, T., Xue, B., Jang, M. S., & Yang, H. Y. (2026). CD44 Receptor-Guided Hyaluronic Acid Nanogels with Dual-Stimuli Responsiveness and Lysosomal Disruption Capability for In Vivo Protein Delivery in Lung Cancer Treatment. Biomacromolecules. https://doi.org/10.1021/acs.biomac.6c01379

Vancouver

Jiang W, Sun W, Zhan S, Liu C, Sheng L, Fu Y, et al. CD44 Receptor-Guided Hyaluronic Acid Nanogels with Dual-Stimuli Responsiveness and Lysosomal Disruption Capability for In Vivo Protein Delivery in Lung Cancer Treatment. Biomacromolecules. 2026. doi:10.1021/acs.biomac.6c01379

BibTeX
@article{Jiang2026,
  author = {Jiang, Wei and Sun, Wei and Zhan, Siqi and Liu, Changling and Sheng, Li and Fu, Yan and Lee, Jung Hee and Liu, Tianjia and Xue, Baiji and Jang, Moon-Sun and Yang, Hong Yu},
  title = {CD44 Receptor-Guided Hyaluronic Acid Nanogels with Dual-Stimuli Responsiveness and Lysosomal Disruption Capability for In Vivo Protein Delivery in Lung Cancer Treatment},
  journal = {Biomacromolecules},
  year = {2026},
  doi = {10.1021/acs.biomac.6c01379}
}
Kostenlos starten →